TipRanks
Palvella Therapeutics (DE:PI6)
FRANKFURT:PI6
Germany Market
PI6
Palvella Therapeutics
RESEARCH TOOLSreports

Palvella Therapeutics (PI6) Stock News & Sentiment

0 Followers
Palvella Therapeutics: Strong Cash Runway and High-Confidence QTORIN Rapamycin Outlook Underpin New Buy Rating
Premium
Ratings
Palvella Therapeutics: Strong Cash Runway and High-Confidence QTORIN Rapamycin Outlook Underpin New Buy Rating
2M ago
PVLA
High-Risk Warning for Investors in Palvella Therapeutics Securities
Premium
Company Announcements
High-Risk Warning for Investors in Palvella Therapeutics Securities
2M ago
PVLA
Palvella Therapeutics Charts Clear Path From Data To Launch
Premium
Company Announcements
Palvella Therapeutics Charts Clear Path From Data To Launch
2M ago
PVLA
Palvella details QTORIN progress and Nasdaq uplisting milestones
Premium
Company Announcements
Palvella details QTORIN progress and Nasdaq uplisting milestones
2M ago
8K
PVLA
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
Premium
TipRanks Newswire
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
3M ago
PTN
CRNX
Analyst Reiterates Buy on Palvella, Sees Market Overreaction to CVM Setback and Maintains $227 Price Target
Premium
Ratings
Analyst Reiterates Buy on Palvella, Sees Market Overreaction to CVM Setback and Maintains $227 Price Target
3M ago
PVLA
Palvella Pharmaceuticals: Buy Rating Reiterated as QTORIN Regulatory Path Stays Intact; Price Target Unchanged at $225
Premium
Ratings
Palvella Pharmaceuticals: Buy Rating Reiterated as QTORIN Regulatory Path Stays Intact; Price Target Unchanged at $225
3M ago
PVLA
More DE:PI6 News >

PI6 News on the Web

First Light Asset Management, LLC Adds 1. ...
GuruFocus News
Neutral
Palvella Therapeutics Slides After Big Drug Hype
TipRanks News
Neutral
Palvella Therapeutics Director Makes Eye-Catching Insider Move in Latest Stock Transaction
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Protagonist Therapeutics (PTGX)
TipRanks News
Bullish
Biotech Darling Palvella Suddenly Slumps As Optimism Fades
TipRanks News
Neutral
MONTANOVA CAPITAL, LLC Trims Veradermics Inc (MANE) Stake in Recent 13DG Filing
GuruFocus News
Neutral
PRUDENTIAL FINANCIAL INC Establishes New Position in Palvella Therapeutics Inc (PVLA)
GuruFocus News
Neutral
Jennison Associates Expands Palvella Therapeutics (PVLA) Stake in June Transaction
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
DE:PI6
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PI6’s Media Buzz Sentiment?
1 articles about DE:PI6 were published this week. In an average week, 2 articles are published.
    What is DE:PI6’s weekly average amount of articles?
    In an average week, 2 articles about DE:PI6 are published.
      What is DE:PI6’s News Sentiment?
      100% of articles about DE:PI6 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week